molecule

Key Points :

• Retinoic acid (RA) is involved in the induction of neural differentiation, motor neuron axon outgrowth and neural patterning during development, but there is growing evidence that RA could be used as a therapeutic molecule for the induction of axon regeneration and the treatment of neurodegeneration.
• RA is a metabolic product of vitamin A (retinol) that signals in both a paracrine and an autocrine manner.
• During development, RA is required for hindbrain patterning and, together with sonic hedgehog and bone morphogenetic proteins, for patterning the dorsoventral axis of the neural tube.
• RA also induces the differentiation of various types of neurons and glia, by activating the transcription of genes that encode various transcription factors, cell signalling molecules, structural proteins, enzymes and cell-surface receptors. This ability can be harnessed to induce the differentiation of stem cells into neural cell types, which could then be used for therapeutic transplantation.
• In peripheral nerves, RA stimulates the regenerative response. In this case it does not necessarily act directly on the neuron: Schwann cells and macrophages might be targets of RA.
• In the mature CNS, RA has a role in the maintenance of plasticity and neural stem cell production. Together with data that implicate a loss of RA signalling in the aetiology of Parkinson's disease, motor neuron disease and Alzheimer's disease, these findings highlight the potential of RA replacement as a therapeutic strategy for treating these conditions.

Abstract :

Retinoic acid (RA) is involved in the induction of neural differentiation, motor axon outgrowth and neural patterning. Like other developmental molecules, RA continues to play a role after development has been completed. Elevated RA signalling in the adult triggers axon outgrowth and, consequently, nerve regeneration. RA is also involved in the maintenance of the differentiated state of adult neurons, and disruption of RA signalling in the adult leads to the degeneration of motor neurons (motor neuron disease), the development of Alzheimer's disease and, possibly, the development of Parkinson's disease. The data described here strongly suggest that RA could be used as a therapeutic molecule for the induction of axon regeneration and the treatment of neurodegeneration.

(Source : Nature)

Retinol is one of several vitamin-A-derived molecules used on the skin. In plain terms, when you apply retinol to your skin it is converted inside skin cells into the active molecule (retinoic acid) that can enter the nucleus of a cell and change which genes are turned on or off. Those gene changes affect how quickly skin cells renew, how much structural protein the skin makes, and how the enzymes that break down connective tissue behave. (MDPI)

Those molecular actions explain why retinol can help with fine wrinkles. First, retinoic signaling increases the skin’s production of collagen — the protein that gives the deeper layer of skin (the dermis) strength and plumpness — and it can reduce the activity of matrix-degrading enzymes (matrix metalloproteinases) that otherwise chew up collagen after sun damage. Second, retinol speeds turnover of the outer skin layer, which smooths rough texture and makes shallow lines less visible. Over months these effects can lead to a thicker, firmer dermis and improved surface appearance, which is what people see as “filling in” or softening of fine wrinkles. (MDPI)

What the clinical evidence shows is that prescription retinoids (for example tretinoin) have the strongest and most consistent proof that they reduce fine wrinkles and photodamage when used regularly, and many randomized trials and systematic reviews support that benefit. Over-the-counter retinol products also show benefit in studies, but because retinol must be converted in the skin to the active form, it is generally slower and less potent than prescription tretinoin; nonetheless, well-formulated retinol preparations can produce measurable improvements when used consistently. This pattern—strong, long-term evidence for prescription retinoids and good but somewhat weaker/slower evidence for OTC retinol—is what clinical trials and reviews of photoaging report. (ResearchGate)

It’s important to set realistic expectations. Improvements in texture and fine lines typically take months to appear: many reports say people begin to see changes after about three to six months of regular use, with fuller benefits by six to twelve months. Retinol and related retinoids do not erase deep wrinkles overnight; they modify skin structure slowly by changing protein production and cell turnover. Daily sun protection is crucial while using retinoids because the skin can be more sensitive to UV light during the adjustment period. (Harvard Health)

Retinol use also carries trade-offs. Early in treatment some people experience redness, dryness, flaking, and irritation — these are common as the skin adjusts. Because stronger prescription retinoids are more active, they tend to cause more irritation but also produce faster and larger effects; retinol is often recommended as a gentler starter option. Dermatology groups advise introducing retinoids gradually, using moisturizers to improve tolerance, and applying sunscreen daily. (Académie Américaine de Dermatologie)

In short: retinol works by converting to a retinoic form that changes gene activity, which increases collagen, tampers down collagen-degrading enzymes, and speeds surface cell renewal—biological changes that reduce the appearance of fine wrinkles over months. Prescription retinoids have the strongest clinical proof, but over-the-counter retinol can help too if used consistently and with sensible sun protection and irritation-management. (MDPI)

(Source : ChatGPT) (Image : Grok)

Suramin can produce real and sometimes serious harm, and understanding the likely side effects together with the biological reasons they happen helps explain why the drug is used only in tightly controlled settings. Below I explain the main dangers, what people actually experience, and the mechanisms scientists think are responsible — in plain language.

The single most important clinical danger is nerve injury: suramin commonly causes a dose-related peripheral neuropathy. Patients treated with suramin in cancer and other trials have developed numbness, tingling, weakness in the hands and feet and, in some cases, a more severe demyelinating syndrome resembling Guillain–Barré. This is not a subtle lab finding — neuropathy was frequently dose-limiting in older clinical studies and appears in many modern safety reviews. The neuropathy is thought to arise because suramin is a charged molecule that distributes to peripheral nerves and interferes with normal neuronal signalling and axonal function; because it does not readily cross the blood–brain barrier, the problem predominantly affects the peripheral nervous system. (PMC)

Kidney damage is another major and well-documented risk. Clinical records and trial summaries report rises in serum creatinine, proteinuria and clinically significant renal impairment in a substantial minority of patients, and preclinical studies show that suramin accumulates in kidney tissue. The likely mechanisms are multifactorial: direct toxic effects on renal tubular cells (partly from local drug accumulation), interference with growth-factor signalling that helps maintain renal architecture, and indirect effects from systemic changes such as altered coagulation or inflammatory responses. Because the kidneys concentrate and retain suramin, renal toxicity is both common and important to monitor. (ScienceDirect)

Suramin has a very long plasma half-life and sticks to proteins and tissues, which makes side effects persistent. Pharmacokinetic studies show elimination half-lives measured in weeks (commonly reported in the range of ~30–60 days), and suramin can be detected in urine or plasma for many weeks to months after a dose. The consequence is that adverse effects may appear late, worsen with repeated dosing, and take a long time to resolve after stopping the drug — so even a small overdose or an otherwise modest toxic effect can become prolonged. This very slow clearance narrows the gap between an effective dose and a harmful one. (PubMed)

Beyond nerves and kidneys, suramin causes a range of systemic toxicities. Infusion or hypersensitivity reactions, skin rashes and severe dermatologic events (including rare reports of toxic epidermal necrolysis), bone-marrow suppression (leading to anemia, neutropenia or thrombocytopenia), elevated liver enzymes, and general constitutional symptoms (fatigue, nausea) have all been reported. Suramin has also been associated with coagulopathy and, in older reports, with adrenal insufficiency and multiorgan problems when toxicity is severe. These effects reflect both immune/hypersensitivity phenomena and the drug’s broad interference with multiple cellular pathways. (Mayo Clinic)

Mechanistically, suramin’s harms flow logically from what the molecule does at the molecular level. Suramin is a large, highly negatively charged (polyanionic) compound that binds to many proteins on cell surfaces and in extracellular fluid. It blocks multiple purinergic receptors (P2X and P2Y families) and also interferes with growth-factor receptors and other signalling proteins. Blocking purinergic receptors can reduce harmful inflammation in some situations, but those same receptors are also needed for normal nerve signalling, renal tubular transport, immune surveillance and wound repair. Similarly, inhibiting growth-factor pathways can slow tumour growth in some models but also impair the survival and maintenance of normal cells (including neurons, kidney cells, and bone marrow progenitors). The combination of broad receptor blockade plus tissue accumulation explains why suramin’s side effects are both varied and sometimes severe. (PMC)

There are also specific molecular processes implicated in particular toxicities. For example, blocking P2X7 and related purinergic signalling can alter calcium fluxes and inflammasome activation in immune cells — effects that can be anti-inflammatory in one context but disruptive in another. Neuronal dysfunction may result from disturbed ion channel activity and impaired neurotrophic (growth-factor) signalling. Renal injury likely reflects direct tubular cell exposure and disrupted local signalling needed for normal filtration and reabsorption. Bone-marrow effects probably reflect interference with cytokine/growth-factor pathways that control blood cell production. Because suramin hits many of these systems at once, multiple organ systems can be affected simultaneously. (Frontiers)

Clinically, those facts translate into clear cautions. Suramin is given intravenously and requires careful dose selection, baseline assessment of kidney function and blood counts, and close monitoring during and for many weeks after treatment. Repeated dosing risks accumulation and delayed toxicity; symptoms such as new numbness, weakness, changes in urine output, unexpected bleeding or signs of infection should prompt immediate medical review. Because of the toxicity profile and the availability of safer, more selective drugs for most conditions, suramin today is reserved for a very small set of indications or tightly controlled experimental protocols. (Dove Medical Press)

In short, suramin’s dangers are not random — they stem from the drug’s non-selective blockade of multiple cell-surface receptors and growth signals combined with very slow elimination and tissue accumulation. That biological picture explains why the observed side effects cluster in the nervous system, the kidneys, the blood and the skin, and why those effects can be prolonged and clinically serious. For these reasons, any use of suramin must be medically supervised, limited to appropriate indications or clinical trials, and accompanied by careful monitoring. (PMC)

(Source : ChatGPT)

Suramin is an old, powerful medicine with a very specific set of benefits — and also significant risks. Below I’ll explain, in plain language and with simple science, what suramin can do for health, how it works in broad terms, where evidence is strong versus still preliminary, and why it must be used under careful medical supervision.

Suramin’s clearest and best-established health benefit is as an anti-parasitic drug for African sleeping sickness (human African trypanosomiasis). It kills or stops the growth of the tiny parasites that cause the early (blood and lymph) stage of this disease, and because of that it can prevent the very serious consequences of untreated infection. For that reason suramin appears on major public-health medicine lists and is used in places where the disease occurs; it is supplied as an injection and given under medical supervision. (ICCP Portal)

Beyond parasitic disease, suramin has broad effects on biological signalling that led researchers to test it for other health problems. At the molecular level suramin binds to and blocks a variety of signalling molecules and receptors — for example, it interferes with certain growth factors and with “purinergic” signalling (cell communication that uses molecules like ATP). Those actions can slow parasite metabolism, but they also affect human cells. Because many cancers rely on growth-factor signalling, suramin was investigated as an anti-cancer agent: laboratory and early clinical work showed it can block tumour-promoting signals and, in some small trials, produced anti-tumour effects. However, the cancer results were mixed and the drug’s toxicity limited how useful it became for mainstream cancer treatment. (PubMed)

Another area where suramin has attracted attention is neurological and developmental conditions. In small, carefully controlled research studies, a very low single dose of suramin produced short-term improvements in behavior and communication in a tiny group of children with autism spectrum disorder, and similar effects were seen in mouse models. These results are intriguing because they suggest that blocking certain extracellular signalling pathways might change brain inflammation or metabolism in ways that briefly improve symptoms. But these studies were small, early-stage, and temporary effects faded over weeks; they are not proof that suramin is a safe, effective treatment for autism in general. Larger, longer trials would be required before anyone could recommend it for that purpose. (PMC)

Because suramin acts on many biological pathways it can also cause serious side effects. The most important health caveat is toxicity: suramin can damage nerves (causing peripheral neuropathy), affect kidney function, and cause other systemic problems. Past clinical experiences and animal studies show that neurotoxicity and renal effects are dose-related and can be severe, so dosing and patient monitoring are critical. For these reasons suramin is given in controlled medical settings (intravenous administration with clinical monitoring) and its use outside approved or carefully supervised trials is unsafe. (PMC)

To sum up the balance of benefits and risks in plain language: suramin is a legitimate, sometimes life-saving drug for specific parasitic infections (notably the early stage of African sleeping sickness). Its ability to block multiple signalling pathways has made it a candidate for treating other conditions — cancer, certain inflammatory or metabolic problems, and even experimental autism treatments — but the evidence outside parasitic disease is preliminary, mixed, and limited by safety concerns. Because the same properties that give suramin potential benefits also produce significant side effects, it must only be used where benefits clearly outweigh risks and under experienced medical care or within approved clinical trials. (ICCP Portal)

(Source : ChatGPT)

Glutathione is made inside your cells from three amino acids — cysteine, glutamate and glycine — so the easiest way diet helps is by supplying those building blocks and the nutrients that let the body make and recycle glutathione. Of the three precursors, cysteine is usually the most limiting, so eating foods that supply sulfur-containing amino acids supports production. Good dietary sources include protein-rich foods such as eggs, poultry, lean meat, fish, dairy (whey protein is particularly rich in cysteine), and legumes; these provide the amino-acid raw material your liver and other tissues need to synthesise glutathione.

Beyond precursors, several vitamins and minerals help glutathione work and be renewed. Vitamin C and vitamin E act as complementary antioxidants and help recycle oxidized glutathione back to its active form. Selenium is an essential cofactor for glutathione peroxidase, an enzyme that uses glutathione to remove harmful peroxides; selenium-rich foods like Brazil nuts, seafood and whole grains therefore support the system. B-group vitamins and adequate overall protein intake also help because they support general metabolism and the pathways that supply glutamate and glycine.

Certain plant compounds stimulate the body’s own glutathione production by turning on protective genes. Compounds found in cruciferous vegetables (for example broccoli, Brussels sprouts, and kale) — especially sulforaphane — activate cellular antioxidant response pathways (commonly called Nrf2), which upregulate enzymes involved in glutathione synthesis and regeneration. Allium vegetables (garlic, onions), green tea polyphenols, and some other phytochemicals have similar mild activating effects. Eating a variety of colorful vegetables and fruits therefore provides both direct precursors and signals that encourage cells to make and preserve glutathione.

What you avoid in your diet matters too. Chronic alcohol intake, a diet very high in processed foods and refined sugars, and long periods of overeating or nutrient-poor eating increase oxidative stress and can deplete cellular glutathione. Conversely, dietary patterns associated with lower inflammation and oxidative stress — for example Mediterranean-style diets rich in vegetables, fruits, whole grains, nuts, fish and modest amounts of lean protein — are more likely to preserve glutathione over the long term.

Finally, while some fresh foods (asparagus, avocado, spinach) contain measurable glutathione, most ingested glutathione is broken down during digestion; the main benefit of food is supplying precursors and activating protective pathways rather than delivering ready-made glutathione. For people with specific clinical needs or suspected deficiency, clinicians sometimes recommend targeted supplements (such as N-acetylcysteine) because they reliably raise cysteine availability; for general health, a balanced, protein-adequate, plant-rich diet that includes sulfur-containing foods, cruciferous vegetables, vitamin-C rich fruits, and selenium sources is the practical, evidence-based way to boost and preserve your body’s glutathione system.

(Source : ChatGPT)

Glutathione is a small molecule your cells make from three amino acids (glutamate, cysteine and glycine) and it works as a central antioxidant and repair molecule inside nearly every cell. It neutralizes harmful reactive oxygen species directly, and it also acts as a required cofactor for enzymes (for example glutathione peroxidases and glutathione S-transferases) that detoxify peroxides and help remove damaged chemicals from cells. This combined activity helps protect DNA, proteins and membranes from oxidative damage that accumulates with stress, toxic exposures, infection and aging. (PubMed)

Beyond simple antioxidant activity, glutathione is a key player in the body’s detoxification system. Many toxins and drug breakdown products are chemically linked to glutathione (a process called conjugation) so they become easier for the liver and kidneys to eliminate. By participating in these conjugation reactions, glutathione helps reduce the chance that reactive chemicals will injure cellular targets. This detox role is especially important in the liver, where glutathione concentrations and turnover are high. (PMC)

Because glutathione levels fall when cells are exposed to oxidative stress or when precursor supply is limited, researchers have asked whether giving glutathione or its precursors can improve health. Clinical studies and randomized trials show that supplementation can raise circulating glutathione in some settings and reduce markers of oxidative damage and inflammation, with demonstrated benefits in selected groups (for example some older adults and people with metabolic stress). Those trials are encouraging but vary in size and quality, so the strength of evidence differs by condition. (PMC)

How glutathione is delivered matters. Standard oral glutathione is variably absorbed, so many studies use precursors such as N-acetylcysteine (NAC), which reliably raises the body’s own glutathione production, or they use formulations designed for better uptake (liposomal or intravenous glutathione) when a rapid, large increase in blood levels is desired. The choice of form affects how much glutathione actually reaches tissues and therefore the likely benefit. (livemomentous.com)

Safety and practical limits are important. Glutathione supplements are usually well tolerated, but they are not free of risk: inhaled forms have worsened breathing in some people with asthma, and improperly compounded injectable products have caused serious adverse events leading to regulatory warnings. Long-term effects, optimal doses for different conditions, and interactions with medications remain areas of active study, so clinical guidance is recommended before starting high-dose or injected glutathione. (Natures Fix)

In plain terms: glutathione is a natural, powerful defender inside cells that supports antioxidant protection and chemical detoxification. Boosting or preserving glutathione—either through diet, supplying building blocks like cysteine, or, in some clinical settings, by targeted supplementation—can help reduce oxidative stress and support organ health, but the benefits depend on the person’s starting status, the form and dose used, and the medical context. For anyone considering supplements, a clinician can help weigh the existing evidence, choose a delivery method, and monitor safety.

(Source : ChatGPT)

Spermidine is a small organic molecule called a polyamine that cells use for growth, repair and many basic processes. In the human gut it comes from three places: the food we eat, the cells of our own body, and the bacteria that live in the intestine. A range of common gut microbes are able to make spermidine themselves, so the community of bacteria in the intestine helps determine how much of this molecule is present in the gut lumen. (Frontiers)

Not every microbe uses the same recipe. Classic laboratory and animal studies have shown that bacteria from genera often found in the human gut — for example Bacteroides and Fusobacterium — can produce putrescine and spermidine when given appropriate food substrates in the gut, and other groups such as Escherichia, Lactobacillus and Bifidobacterium are also associated with polyamine production in different studies. Those are examples rather than an exhaustive list: many species across different bacterial families carry the enzymes needed to make these molecules, and which species are important can vary with diet and the individual’s microbiome composition. (MDPI)

Biochemically, most bacterial spermidine production follows a two-step idea: bacteria first make putrescine from amino acids (arginine or ornithine) and then convert putrescine into spermidine. Putrescine can be generated by enzymes called decarboxylases (ornithine decarboxylase or arginine decarboxylase, depending on the route). To make spermidine a second set of enzymes is used: S-adenosylmethionine decarboxylase provides an activated propylamine donor and spermidine synthase (often called SpeE) transfers that propylamine onto putrescine to form spermidine. These enzymatic steps are well described in reviews of bacterial polyamine metabolism and explain why many different gut bacteria can contribute to the pool of spermidine. (MDPI)

Some bacteria use alternative chemical routes. A notable example is Campylobacter jejuni, which lacks the standard SpeD/SpeE pair yet still makes spermidine by a different “carboxyspermidine” style pathway. More recently, researchers have discovered further alternative bacterial pathways (for example a carboxy-aminopropylagmatine route reported in 2023) that broaden the kinds of microbes we know can make spermidine. Those alternative pathways matter because they show that spermidine production is widespread and biochemically diverse across the microbiome, not confined to a single canonical pathway. (immunenetwork.org)

Finally, production in the gut is dynamic: what bacteria make depends on what substrates are available (the diet, especially amino acids and fermentable fibers), the presence of particular bacterial strains, and interactions between microbes and host cells that can both supply and take up intermediates. Intervention studies show that adding certain probiotics or dietary components can change microbiome-derived spermidine levels, illustrating that bacterial spermidine output can be modified by what we eat or by changing the resident microbes. In short, multiple gut bacterial groups can produce spermidine through one of several biochemical routes, and diet plus microbial ecology determines how much of that bacterial spermidine ends up in the intestine. (PMC)

(Source : ChatGPT)

Inositol hexaphosphate (IP6), also called phytic acid or “phytate” when in salt form, is a naturally occurring compound found mainly in bran, seeds, legumes and other high-fiber plant foods. In the body it acts as a multitasker: chemically it’s a strong phosphate-rich molecule that can bind metal ions, and biologically it participates in cell signaling and the regulation of growth and stress responses. Those basic properties explain most of the reported health effects. (MDPI)

One frequently described mechanism is antioxidant activity. IP6 can scavenge reactive oxygen species and reduce oxidative damage inside cells, either directly or by helping iron remain in a less reactive form so it does not catalyze harmful free-radical chemistry. By lowering oxidative stress, IP6 can protect tissues from injury in experimental models. (PMC)

A large body of preclinical research (cell culture and animal studies) shows that IP6 influences fundamental processes of cell life: it can slow abnormal cell proliferation, encourage damaged cells to die when appropriate (apoptosis), promote differentiation toward normal cell behavior, and interfere with pathways cancer cells use to survive and spread. These actions, together with immune-modulating effects seen in animals, underlie the interest in IP6 as a chemopreventive and adjunctive agent in cancer research. Animal experiments have repeatedly reported reduced tumor growth and metastasis in several models after IP6 treatment. However, most of this evidence is preclinical—promising but not definitive for routine human use. (PMC)

Beyond cancer models, IP6 has shown beneficial effects in other areas in laboratory and animal studies. Investigators have reported protective effects on organs exposed to toxic drugs, support for intestinal health and barrier function, and signals that IP6 may reduce inflammation and help maintain metabolic and cardiovascular health. Some recent reviews and animal studies also suggest neuroprotective potential (for example in models of Parkinson’s disease), though human data remain sparse. (Nature)

It is important to balance potential benefits with realistic limits and safety considerations. Because IP6 readily binds minerals such as iron, zinc and calcium, high intake from purified supplements or diets very high in phytate can reduce absorption of those trace minerals and, in susceptible populations, contribute to deficiencies. This “antinutrient” behavior is well documented and is the main safety concern for long-term high dosing. Regulatory and nutrition bodies have examined these effects and recommend caution, especially where diets lack diversity or where mineral status is already borderline. (PubMed)

Finally, what does this mean for people? IP6 is biologically active and has a plausible set of mechanisms—antioxidant, metal-binding, cell-signaling modulation—that explain why it produces protective effects in lab and animal studies. Some small human studies and long-term observational data hint at lower cancer rates where diets are rich in whole grains and legumes (the foods that deliver IP6), but large, high-quality clinical trials demonstrating clear, reproducible health benefits of purified IP6 supplements in humans are still limited. For now, the safest, evidence-based approach is to get IP6 as part of a balanced, fiber-rich diet (whole grains, legumes, seeds) rather than high-dose isolated supplements, and to consult a clinician before starting supplements—especially for people who are pregnant, have mineral-absorption issues, or are taking medications. (MDPI)

In short, IP6 is a biologically active plant compound with antioxidant, immune-modulating and cell-regulatory effects that produce convincing protective results in preclinical studies; these findings are promising but not yet strong enough to recommend routine high-dose supplementation for disease prevention without medical guidance.

(Source : ChatGPT)

Retinol is the active form of vitamin A that the eye uses as a chemical building block for seeing. In the retina, retinol is converted into a related molecule called 11-cis-retinal, which fits into light-sensing proteins (opsins) to form rhodopsin and other visual pigments. When light hits those pigments they change shape and trigger the photoreceptor cells to send an electrical signal to the brain — that chain of events is the molecular basis of vision, especially in low light. (ods.od.nih.gov)

This conversion and recycling of retinoids is called the “visual cycle.” After photoreceptors absorb light, the retinal part of the pigment becomes all-trans-retinal and is then reduced to all-trans-retinol; that retinol is shuttled to the retinal pigment epithelium (RPE) and enzymatically converted back to 11-cis-retinal so it can be reused. Specialized carrier proteins (for example interphotoreceptor retinoid-binding protein and retinol-binding protein in the blood) control retinol transport and delivery to the eye. Interruptions anywhere in this cycle — from low dietary supply to problems with transport or enzymes — reduce the eye’s ability to make the light-sensitive chromophore and weaken visual function. (Nature)

The practical effects of inadequate retinol are well documented. The earliest and most noticeable sign is difficulty seeing in dim light (night or twilight blindness). With progressing deficiency the surface tissues of the eye (the conjunctiva and cornea) become dry and damaged — a condition called xerophthalmia — and, in severe cases, this can lead to corneal ulceration and permanent blindness. Public-health programs that prevent or treat vitamin A deficiency reduce these eye problems and the blindness that can follow. (Organisation mondiale de la santé)

For people who are actually deficient in vitamin A, oral retinol (or appropriate vitamin A supplementation) commonly produces real, measurable benefits: night-vision improves, conjunctival and corneal health recovers, and further progression to severe eye disease is prevented. In contrast, adding extra retinol to someone who already has adequate vitamin A does not meaningfully improve visual acuity or night vision and can be harmful if taken in excess. (Organisation mondiale de la santé)

There are safety and clinical points to keep in mind. Vitamin A is fat-soluble and stored in the liver, so chronic high intake of preformed vitamin A (retinol) can cause toxicity; very high doses are teratogenic and must be avoided in pregnancy. People with disorders that impair fat absorption (for example some intestinal diseases) or those on certain medications may become deficient and benefit from medical evaluation and guided supplementation. Because the benefits and risks depend on individual status, testing and medical advice are appropriate if someone suspects a deficiency. (Mayo Clinic)

In short: retinol is essential for the chemical steps that let photoreceptors detect light and for keeping the eye surface healthy. Restoring normal vitamin A levels reliably improves night vision and ocular surface health in deficient people, but it is not a “vision enhancer” for those who already have sufficient vitamin A, and inappropriate dosing carries real risks. (ods.od.nih.gov)

(Source : ChatGPT)

Quote : " Methylene blue has an oxidized phenothiazine ring system, as opposed to many other phenothiazine drugs which have reduced ring systems. This difference has profound effects on action and activity, as it increases the chemical structure’s angle and gives the ring system a positive charge. This allows methylene blue to interact differently with membranes and intracellular structures. For example, staining with methylene blue can be used to show membrane damage. " [x]

The passage you quoted is describing, in short form, how a specific chemical feature of methylene blue — the way its central ring system is chemically “oxidized” and therefore carries a positive charge and a particular three-dimensional shape — changes the way the molecule behaves around cells and cell parts. Here’s a clear, plain-language unpacking of each idea and what it means in practice.

A phenothiazine ring is a three-ring chemical scaffold found in several kinds of molecules. You can think of it as a flat set of connected rings made from carbon and a couple of heteroatoms (sulfur and nitrogen). When chemists say a ring system is “oxidized” they mean that, at one or more positions, electrons have been removed or the atoms carry a formal positive charge compared with a “reduced” version. For methylene blue that oxidized form is stable and the molecule exists as a positively charged ion. That positive charge is a simple but powerful change: many biological surfaces and molecules — cell membranes, nucleic acids, some proteins — carry negative charges, so a positively charged dye is attracted to and binds those negatively charged sites by electrostatic forces.

The text’s comment about the ring system’s “angle” refers to the molecule’s three-dimensional shape. Chemical oxidation can change how flat or bent the ring system is; in methylene blue the structure is not perfectly flat and the positive charge is distributed over the ring system. A change in shape matters because molecules interact physically with membranes and proteins much like puzzle pieces: a flatter molecule might slide between stacked flat structures, while a more bent or angled molecule will sit differently against a curved membrane surface or fit into grooves of proteins in a different way. So, the altered angle plus the positive charge together change where and how strongly methylene blue sticks to membranes and intracellular structures.

Those two properties — positive charge and a particular 3D shape — explain two practical behaviors of methylene blue. First, because it is cationic (positively charged) and somewhat lipophilic, it tends to accumulate in sites with a negative electrical potential, especially mitochondria (the cell’s energy organelles) which have a strongly negative inner membrane potential. That accumulation helps explain why methylene blue can affect cellular energy chemistry and appear in certain parts of the cell under the microscope. Second, as a basic (cationic) dye, methylene blue binds readily to negatively charged cellular material. In microscopy, this is why it stains some tissues or cell compartments: if the dye can reach and bind internal components they will appear colored.

When the sentence says “staining with methylene blue can be used to show membrane damage,” it is referring to a common laboratory idea: intact cell membranes are selective barriers, and a dye that cannot normally cross an intact membrane will be excluded from the cell interior. If the membrane is damaged, the dye can enter and stain inner structures (or stain in a different pattern). That change in staining pattern — for example, cells that suddenly take up blue dye while healthy cells do not — is a practical indicator that membranes have been compromised. In other words, the dye’s entry into parts of the cell it normally can’t reach is used as a sign that the membrane barrier failed.

It is important, however, to be cautious about interpreting such staining. Staining patterns depend on many factors: the exact chemical form of the dye (it can be reduced to a colorless form in some conditions), the concentration used, how long cells are exposed, and the experimental conditions (pH, temperature, presence of proteins that bind the dye). A positive stain is an indicator, not definitive proof, of membrane damage: good experimental practice includes controls (untreated cells, known-damage controls) and complementary tests to confirm that membranes are truly compromised rather than simply more permeable under the test conditions or chemically altered in ways that change dye binding.

In short, the statement is making three linked points that are chemically sensible in broad terms: methylene blue’s oxidized, positively charged phenothiazine core gives it a particular three-dimensional shape and charge distribution; those features change how it associates with membranes and intracellular structures; and because of that, changes in where the dye ends up (how cells stain) can be used as a practical indicator of membrane integrity. The real-world interpretation of staining, though, requires attention to experimental detail and corroborating evidence.

(Source : ChatGPT)